Clinical trial
A Randomized, Double-Blind Trial to Compare the Clinical Efficacy and Safety of Granisetron vs. Metoclopramide Combined to Dexamethasone in the Prophylaxis of Chemotherapy-Induced Delayed Emesis
NCT00003213 is registered in ClinicalTrials.gov with Swiss Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind Trial to Compare the Clinical Efficacy and Safety of Granisetron vs. Metoclopramide Combined to Dexamethasone in the Prophylaxis of Chemotherapy-Induced Delayed Emesis
- Lead sponsor
- Swiss Cancer Institute
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 1996
- Completion date
- August 31, 1999
- Enrollment
- 267 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
nausea and vomiting, unspecified adult solid tumor, protocol specific